Hemosiderosis other imaging findings: Difference between revisions
Jump to navigation
Jump to search
m Template |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Chromium]] and [[technetium]] based perfusion scans show intra-[[alveolar]] [[bleeding]]. Scans with abnormal [[pulmonary]] [[uptake]] 12-24 hours after the [[injection]] have been observed in patients with [[pulmonary hemorrhage]]. | |||
==Other imaging findings== | ==Other imaging findings== | ||
Revision as of 04:26, 28 September 2020
|
Hemosiderosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemosiderosis other imaging findings On the Web |
|
American Roentgen Ray Society Images of Hemosiderosis other imaging findings |
|
Risk calculators and risk factors for Hemosiderosis other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Chromium and technetium based perfusion scans show intra-alveolar bleeding. Scans with abnormal pulmonary uptake 12-24 hours after the injection have been observed in patients with pulmonary hemorrhage.